Therefore, it is possible that the concurrent FA/HR aberrations and ATM/ATR mutations help fine-tune the DDR machinery to introduce enough mutations to drive tumorigenesis/tumor progression while keeping certain levels of genomic integrity to maintain tumor cell survival. This evidence concerns the gene ATR and neoplasm.